Latest California Healthline Stories
A Golden Ticket That Fast-Tracks A Drug Through The FDA
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder — and then used to speed up approvals for much more common drugs.
UnitedHealth And University Of California To Forge Unique Alliance
The nation’s largest insurer and the state’s university health system intend to offer a health plan option to self-funded employers in California and pursue research drawing upon a huge reservoir of patient data.
Deadly Opioid Overwhelms First Responders And Crime Labs in Ohio
Carfentanil, a potent variation on fentanyl, is being blamed for a wave of opioid overdoses. In Cincinnati, the coroner, crime lab and first responders are struggling to keep up.
Twenty dying people, at peace with their mortality, shared their views on life, love and death with a Los Angeles artist for an exhibit at the Museum of Tolerance.
A Practical To-Do List For Family Caregivers
In order to maximize the important role they play, family caregivers must be proactive in speaking up, planning and documenting their ability to meet their loved one’s health care needs.
Poll Finds Majority Of Americans Want Restraints On Drug Prices
As the spiraling costs attract headlines, many people are looking to the government to rein in prescription drug prices, according to the Kaiser Family Foundation poll.
Election Buzz: Critics Of Legal Pot Say Addiction Becomes ‘A Disease Of The Family’
As more states consider legalizing recreational marijuana, families consider what messages to present to young people about using pot. Should it be avoidance, moderation or acceptance? Differing views from Arizona and Oregon.
Specialty Drug Costs Soar 30% For California Pension Fund
Such medications account for more than a quarter of the state agency’s $2.1 billion in pharmacy costs.
It’s In The Water: The Debate Over Fluoridation Lives On In California And Nationwide
Though fluoride has been added to water for decades to prevent tooth decay, grassroots opposition still pops up in towns and cities around the country.
When Drug Reviewers Leave The FDA, They Often Work For Pharma
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.